The North America multiplex assay market is forecasted to register a CAGR of 8.70% during the estimated period of 2021 to 2028. The market growth of the region is reinforced by key drivers such as increasing government funds for the detection of new biomarkers, the growing incidence of chronic conditions including cancer and stroke, and the rising research and development activities associated with new drugs, diagnoses, as well as treatment options.
NORTH AMERICA MULTIPLEX ASSAY MARKET FORECAST 2021-2028
North America Multiplex Assay Market by Type ( Protein-based Multiplex Assay, Nucleic Acid-based Multiplex Assay, Other Multiplex Assays ) Market by Product ( Reagents and Consumables, Instruments and Accessories, Software and Services ) Market by Technology ( Multiplex Protein Microarray, Multiplex Pcr, Other Technologies ) Market by Application ( Clinical Diagnostics, Research and Development, Companion Diagnostics ) Market by End-user ( Hospitals, Clinical Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies ) by Geography.
The North America multiplex assay market is forecasted to register a CAGR of 8.70% during the estimated period of 2021 to 2028. The market growth of the region is reinforced by key drivers such as increasing government funds for the detection of new biomarkers, the growing incidence of chronic conditions including cancer and stroke, and the rising research and development activities associated with new drugs, diagnoses, as well as treatment options.
To know more about this report, request a free sample copy.
The North America multiplex assay market growth assessment includes the analysis of the United States and Canada. As per the 2018 GLOBOCAN report, the number of new cancer cases recorded in the United States equated to 2,129,118, in addition to 616,714 cancer-related deaths. In 2018, the top five prevalent cancers in the country included breast, lung, prostate, colon, and bladder. Moreover, as per the American Cancer Society, the disease is the second leading cause of death in the United States, following heart ailments.
The United States’ expenditure on healthcare is significantly higher than other countries globally. The government spending for the nation’s clinical services laboratory increased by 3% between 2010 to 2017, accounting for over $96 billion. Furthermore, the population in the United States is largely aware of the disease prevention and early diagnoses measures for the treatment and prevention of numerous chronic as well as acute conditions. Hence, these factors are set to propel market growth in North America.
Bio-Rad Laboratories Inc, headquartered in the United States, is a life science research and medical device firm that enables researchers to accelerate the discovery process and assist laboratories in acquiring faster and more enhanced results. The company’s key life sciences products include medical instruments, consumables, software, and reagents, concentrated in the field of gene expression, cell biology, protein quantification, protein purification, and drug discovery and manufacture.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- GOVERNMENTAL FUNDING AND R&D ACTIVITIES
- PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
- ADOPTION OF PERSONALIZED MEDICINES
- KEY RESTRAINTS
- UNAVAILABILITY OF SKILLED LAB TECHNICIANS
- COMPLIANCE WITH STRICT ENVIRONMENTAL REGULATION
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- KEY BUYING CRITERIA
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY TYPE
- PROTEIN-BASED MULTIPLEX ASSAY
- NUCLEIC ACID-BASED MULTIPLEX ASSAY
- OTHER MULTIPLEX ASSAYS
- MARKET BY PRODUCT
- REAGENTS AND CONSUMABLES
- INSTRUMENTS AND ACCESSORIES
- SOFTWARE AND SERVICES
- MARKET BY TECHNOLOGY
- MULTIPLEX PROTEIN MICROARRAY
- MULTIPLEX PCR
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- CLINICAL DIAGNOSTICS
- RESEARCH AND DEVELOPMENT
- COMPANION DIAGNOSTICS
- MARKET BY END-USER
- HOSPITALS
- CLINICAL LABORATORIES
- RESEARCH INSTITUTES
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- ABCAM
- AGILENT TECHNOLOGIES INC
- BECTON, DICKINSON AND COMPANY (BD)
- BIO-RAD LABORATORIES INC
- BIO-TECHNE CORPORATION
- HOFFMANN-LA ROCHE
- ILLUMINA INC
- LUMINEX CORPORATION
- MERCK MILLIPORE
- OLINK PROTEOMICS AB
- QIAGEN NV
- RANDOX LABORATORIES LTD
- SEEGENE INC
- SIEMENS HEALTHINEERS AG
- THERMO FISHER SCIENTIFIC INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MULTIPLEX ASSAY
TABLE 2: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: LEADING PLAYERS OPERATING IN THE NORTH AMERICA MULTIPLEX ASSAY MARKET
TABLE 15: LIST OF MERGERS & ACQUISITIONS
TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 18: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, IN 2020
FIGURE 6: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, IN 2020
FIGURE 10: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, IN 2020
FIGURE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
FIGURE 16: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, IN 2020
FIGURE 19: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END-USER, IN 2020
FIGURE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 26: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 27: NORTH AMERICA MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 28: UNITED STATES MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: CANADA MULTIPLEX ASSAY MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY TYPE
- PROTEIN-BASED MULTIPLEX ASSAY
- NUCLEIC ACID-BASED MULTIPLEX ASSAY
- OTHER MULTIPLEX ASSAYS
- MARKET BY PRODUCT
- REAGENTS AND CONSUMABLES
- INSTRUMENTS AND ACCESSORIES
- SOFTWARE AND SERVICES
- MARKET BY TECHNOLOGY
- MULTIPLEX PROTEIN MICROARRAY
- MULTIPLEX PCR
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- CLINICAL DIAGNOSTICS
- RESEARCH AND DEVELOPMENT
- COMPANION DIAGNOSTICS
- MARKET BY END-USER
- HOSPITALS
- CLINICAL LABORATORIES
- RESEARCH INSTITUTES
- PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.